{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:52:01Z","timestamp":1790621521033,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.lungcan.2015.07.015","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T12:32:03Z","timestamp":1438259523000},"page":"55-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT"],"prefix":"10.1016","volume":"90","author":[{"given":"Roslyn J.","family":"Francis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Segard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Morandeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.C. Gary","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Millward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2015.07.015_bib0005","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2015.07.015_bib0010","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.ejca.2011.05.012","article-title":"Re-evaluating the role of palliative radiotherapy in malignant pleural mesothelioma","volume":"47","author":"Jenkins","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lungcan.2015.07.015_bib0015","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0360-3016(98)00409-X","article-title":"Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura\u2014a single-institution experience with 189 patients","volume":"43","author":"de Graaf-Strukowska","year":"1999","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2015.07.015_bib0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2005.06.038","article-title":"Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study","volume":"77","author":"Nordsmark","year":"2005","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.lungcan.2015.07.015_bib0025","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1158\/1078-0432.CCR-05-1773","article-title":"Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer","volume":"12","author":"Rajendran","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2015.07.015_bib0030","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1200\/JCO.2005.05.2878","volume":"24","author":"Rischin","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2015.07.015_bib0035","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1367","article-title":"Exploiting tumour hypoxia in cancer treatment","volume":"4","author":"Brown","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lungcan.2015.07.015_bib0040","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1200\/JCO.2007.12.7878","article-title":"Hypoxic radiosensitization: adored and ignored","volume":"25","author":"Overgaard","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2015.07.015_bib0045","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.semnuclmed.2007.07.001","article-title":"Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole","volume":"37","author":"Lee","year":"2007","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.lungcan.2015.07.015_bib0050","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2967\/jnumed.113.126615","article-title":"A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers","volume":"55","author":"Carlin","year":"2014","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.lungcan.2015.07.015_bib0055","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1007\/s00259-006-0175-6","article-title":"FDG\u2014a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2-polarography in metastatic head and neck cancer","volume":"33","author":"Zimny","year":"2006","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.lungcan.2015.07.015_bib0060","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3109\/0284186X.2010.516274","article-title":"Identifying hypoxia in human tumors: a correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode","volume":"49","author":"Mortensen","year":"2010","journal-title":"Acta Oncol."},{"key":"10.1016\/j.lungcan.2015.07.015_bib0065","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2967\/jnumed.110.075663","article-title":"Molecular imaging of hypoxia","volume":"52","author":"Chitneni","year":"2011","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.lungcan.2015.07.015_bib0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2012.08.019","article-title":"Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer","volume":"105","author":"Zips","year":"2012","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.lungcan.2015.07.015_bib0075","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1158\/1078-0432.CCR-09-2313","article-title":"A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters","volume":"16","author":"Nowak","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2015.07.015_bib0080","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2967\/jnumed.107.042333","article-title":"Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans","volume":"48","author":"Francis","year":"2007","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.lungcan.2015.07.015_bib0085","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cpet.2011.04.001","article-title":"Multimodality imaging review of malignant pleural mesothelioma diagnosis and staging","volume":"6","author":"Gerbaudo","year":"2011","journal-title":"PET Clin."},{"key":"10.1016\/j.lungcan.2015.07.015_bib0090","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s00259-010-1704-x","article-title":"FDG PET\/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival","volume":"38","author":"Gerbaudo","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.lungcan.2015.07.015_bib0095","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0360-3016(96)00325-2","article-title":"Quantifying regional hypoxia in human tumors with positron emission tomography of [18F] fluoromisonidazole: a pretherapy study of 37 patients","volume":"36","author":"Rasey","year":"1996","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2015.07.015_bib0100","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1007\/s00259-005-1880-2","article-title":"Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent","volume":"32","author":"Hicks","year":"2005","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.lungcan.2015.07.015_bib0105","first-page":"253","article-title":"Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy","volume":"46","author":"Eschmann","year":"2005","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.lungcan.2015.07.015_bib0110","first-page":"1921","article-title":"Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-fluoromisonidazole and 18F-FDG PET","volume":"47","author":"Cherk","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.lungcan.2015.07.015_bib0115","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1158\/1078-0432.CCR-0688-3","article-title":"Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging","volume":"10","author":"Rajendran","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2015.07.015_bib0120","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/JTO.0b013e31825f22ee","article-title":"A phase II study of intermittent sunitinib malate as second-line therapy in progressive malignant pleural mesothelioma","volume":"7","author":"Nowak","year":"2012","journal-title":"J. Thorac. Oncol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500215300210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500215300210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T15:20:04Z","timestamp":1537456804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500215300210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0169500215300210"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2015.07.015","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2015.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2015 Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}